Invention Grant
US07807691B2 Substituted N-arylpyrrolidines as selective androgen receptor modulators
有权
取代的N-芳基吡咯烷酮作为选择性雄激素受体调节剂
- Patent Title: Substituted N-arylpyrrolidines as selective androgen receptor modulators
- Patent Title (中): 取代的N-芳基吡咯烷酮作为选择性雄激素受体调节剂
-
Application No.: US11913710Application Date: 2006-05-10
-
Publication No.: US07807691B2Publication Date: 2010-10-05
- Inventor: Konstantinos Gavardinas , Prabhakar Kondaji Jadhav , Douglas Richard Stack
- Applicant: Konstantinos Gavardinas , Prabhakar Kondaji Jadhav , Douglas Richard Stack
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Alexander Wilson
- International Application: PCT/US2006/018061 WO 20060510
- International Announcement: WO2006/124447 WO 20061123
- Main IPC: A61K31/4025
- IPC: A61K31/4025 ; C07D207/06 ; C07D207/08 ; C07D207/10
Abstract:
The present invention provides a compound of the Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly frailty, osteoporosis, osteopenia, and male and female sexual dysfunction comprising administering to a patient in need thereof an effective amount of a compound of Formula (I).
Public/Granted literature
- US20080176864A1 Substituted N-Arylpyrrolidines as Selective Androgen Receptor Modulators Public/Granted day:2008-07-24
Information query
IPC分类:
